- Stocks
- Healthcare
- NASDAQ: GH

Price (delayed)

$135.39

Market cap

$13.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.38

Enterprise value

$14.16B

Sector: Healthcare

Industry: Diagnostics & Research

Guardant Health's revenue has increased by 21% YoY and by 3.9% from the previous quarter

The gross profit has grown by 18% YoY

GH's equity is down by 35% QoQ but it is up by 8% YoY

The debt has surged by 58% since the previous quarter

Guardant Health's net income has decreased by 32% QoQ

What are the main financial stats of GH

Market
Valuations
Earnings

Shares outstanding

101.12M

Market cap

$13.69B

Enterprise value

$14.16B

Price to earnings (P/E)

N/A

Price to book (P/B)

16.05

Price to sales (P/S)

45.88

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

47.55

Revenue

$297.89M

EBIT

-$329.84M

EBITDA

-$304.06M

Free cash flow

-$160.98M

Per share
Balance sheet
Liquidity

EPS

-$3.38

Free cash flow per share

-$1.59

Book value per share

$8.43

Revenue per share

$2.95

TBVPS

$23.06

Total assets

$2.35B

Total liabilities

$1.44B

Debt

$1.34B

Equity

$847.05M

Working capital

$1.94B

Debt to equity

1.59

Current ratio

21.29

Quick ratio

20.82

Net debt/EBITDA

-1.56

Margins
Efficiency
Dividend

EBITDA margin

-102.1%

Gross margin

66.2%

Net margin

-112.7%

Operating margin

-110.1%

Return on assets

-18.8%

Return on equity

-30.9%

Return on invested capital

-18.7%

Return on capital employed

-14.7%

Return on sales

-110.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Guardant Health stock price performed over time

Intraday

0.57%

1 week

-14.84%

1 month

-14.33%

1 year

61.27%

YTD

5.05%

QTD

-11.31%

How have Guardant Health's revenue and profit performed over time

Revenue

$297.89M

Gross profit

$197.11M

Operating income

-$327.9M

Net income

-$335.71M

Gross margin

66.2%

Net margin

-112.7%

The company's operating margin has shrunk by 188% YoY and by 24% QoQ

Guardant Health's net income has decreased by 32% QoQ

GH's operating income is down by 29% from the previous quarter

The net margin has declined by 27% since the previous quarter

What is Guardant Health's growth rate over time

What is Guardant Health stock price valuation

P/E

N/A

P/B

16.05

P/S

45.88

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

47.55

The EPS has declined by 30% since the previous quarter

The P/B is 42% more than the last 4 quarters average of 11.3

GH's equity is down by 35% QoQ but it is up by 8% YoY

Guardant Health's revenue has increased by 21% YoY and by 3.9% from the previous quarter

The P/S is 10% above the last 4 quarters average of 41.7

How efficient is Guardant Health business performance

GH's ROA has dropped by 132% year-on-year and by 7% since the previous quarter

Guardant Health's ROIC has plunged by 73% YoY but it has increased by 5% from the previous quarter

The ROE has contracted by 30% from the previous quarter

The return on sales has declined by 28% since the previous quarter

What is GH's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for GH.

How did Guardant Health financials performed over time

Guardant Health's total assets is 63% more than its total liabilities

GH's current ratio has surged by 188% year-on-year but it is down by 25% since the previous quarter

Guardant Health's total assets has soared by 148% YoY and by 3.3% from the previous quarter

The debt is 59% greater than the equity

GH's debt to equity has surged by 145% since the previous quarter

The debt has surged by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.